Herbal formula for advanced liver cancer with damp-heat syndrome
Part of Cancer, Digestive system clinical trials.
This trial is testing a traditional Chinese herbal formula to see if it helps people with advanced liver cancer who are about to get a second or third treatment. It may work better than standard care alone for those with a 'damp-heat' syndrome, which is a traditional Chinese medicine way of describing certain symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with primary liver cancer (cancer that started in your liver).
- Your liver cancer is classified as stage C according to the Barcelona Clinic Liver Cancer (BCLC) system, which means it is advanced or has spread.
- You are planning to start your second or third line of treatment for your liver cancer.
- In traditional Chinese medicine diagnosis, your condition is characterized by 'damp-heat' pattern (symptoms may include yellowing of skin or eyes, bitter taste, or feeling of heaviness).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of liver-directed chemotherapy (HAIC), an immunotherapy drug (sintilimab), and a drug that blocks blood vessel growth (bevacizumab biosimilar) for advanced liver cancer that hasn't been treated with systemic therapy before. The goal is to see if this triple therapy can shrink or control the cancer.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This trial is testing a combination of treatments for liver cancer that cannot be removed by surgery. It combines a targeted therapy pill (lenvatinib), an immunotherapy that boosts your immune system (PD-1 blocker), a procedure that destroys tumors with heat or cold (ablation), and a chemo procedure that delivers medicine directly to the liver (TACE). The goal is to see if this mix is safe and effective.
This study is testing whether combining targeted therapy with immunotherapy (or using two immunotherapies together) can help people with liver cancer that cannot be surgically removed. The goal is to understand how well these treatments work and how they affect biomarkers (signals in your body that show treatment response).
This study tests a combination treatment for liver cancer that has not spread to other organs. It combines two procedures that deliver chemo directly to the liver (HAIC and TACE) with two medications (apatinib and camrelizumab) that help your immune system fight the cancer.
This trial tests a combination of two treatments for advanced liver cancer that cannot be removed by surgery. One treatment delivers chemotherapy directly to the tumor, and the other uses tiny beads to block the tumor's blood supply. This approach may help shrink tumors and slow the cancer's growth.
Hear when a new Chinese Herbal Medicine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.